Aleon Pharma

Executive Summary

Aleon Pharma is a strategic regulatory affairs consulting firm specializing in guiding drug and biologics development from IND through NDA/BLA approval. Founded in 2018 and headquartered in San Diego with additional offices in New Jersey and Suzhou, China, the company provides high-quality regulatory, clinical, and pharmacovigilance services to biopharmaceutical sponsors globally. As a private company without a disclosed product pipeline, Aleon Pharma's value is derived from its expertise in navigating complex regulatory pathways, particularly for oncology and small molecule therapeutics. Its dual US-China presence positions it to capture cross-border opportunities, though the company faces competition from larger consulting firms and internal capabilities of its clients. Given its service-based model, conviction is moderate as revenue growth hinges on successful client engagements and regulatory outcomes.

Upcoming Catalysts (preview)

• Q3 2026Expansion into Biologics and Gene Therapy Consulting60% success
• Q4 2026Key Client FDA Approval or NDA Submission40% success
• Q1 2027Strategic Partnership with a Top 20 Pharma Company30% success